THE BIOCYN®TECHNOLOGY

In the healthcare world there is no proverbial “silver bullet” when it comes to controlling the spread of infectious microorganisms. It is for this reason there are so many products in the marketplace; some for bacteria, some for viruses and others for yeast and fungal infections. Most contain the same ingredients of varying concentrations and are marketed for a variety of different maladies. If the infection is misdiagnosed, then the use of some of these products can actual hinder not help the recovery process.

BIOCYN® is a broad spectrum antimicrobial formulation which uses a catalytic process to be manufactured. That process converts oxygen into a reactive form which then integrates natural EPA/FDA ingredients with oxygen activated water. By doing so, BIOCYN® increases the solubility of the critical ingredients, reduces their concentration levels and creates a synergistic effectiveness. The BIOCYN® formulation consists of an oxygen activated zinc, sulfur, iodophor, methyl salicylate, polyquaterium complex. As independent chemistries, each requires a significantly higher concentration to achieve effectiveness against any specific organism. By catalytically combining the ingredients, a broad spectrum antimicrobial capability to inhibit the reproductive cycles of bacteria, viruses, fungi, yeast and mold is achieved. Further, each ingredient typically requires a solvent based delivery fluid to make them usable, which would make them either mildly toxic or dermal irritating. Through the use of the catalytic process, a normally solvent based technology becomes water based-totally non-toxic, non-mutagenic, non-skin irritating and environmentally and biologically safe.

In order to accomplish an effective wound healing process, all infection factors must be considered, including the nature of the wound, the pain associated with the trauma and the   type of infection that is present. For the treatment of chronic wounds and/or those which  exhibit bio-film tendencies, a simple antimicrobial treatment process is not effective. Due to the nature of bio-film production, techoic acid lattices covalently bond microbial structures   together through complex protein interaction. The effective treatment of such conditions requires that these protein structures are “disconnected”, ATP conversion interrupted and cellular DNA.

BIOCYN’s active complex functions simultaneously on several levels. BIOCYN®’s reactive oxygen component, perozone, works in concert with a polyquaterium/zinc complex to solubilize microorganism membranes, altering microbial enzyme production while changing the surface tension of the treated surface. This surface tension adjustment allows for highly efficient cleansing and rapid removal of contamination from the affected area. The sulfur/polyquaterium complex is dispersed within the microorganism’s cytoplasm where it combines with sulfhydryl groups on cellular proteins, thereby inhibiting their function and preventing future reproduction. This complex metabolic process interrupts the efflux inhibitor function within the cells thereby insuring that there is virtually no possibility the pathogens will mutate into more treatment resistant strains. Confusion occurs when it is assumed that BIOCYN is simply a peroxide based product and the primary mode of operation is the oxidation of the cell  wall.

BIOCYN does not use peroxide as most infectious organisms such as MRSA and Pseudomonas are catalase positive and effectively combat oxidative attacks on their matrix. The reactive  oxygen chemistry is generated to create an effective sulfide antimicrobial complex. During the manufacturing process, the concentration of reactive oxygen is critical. If not properly regulated the sulfur complex would be rapidly converted to sulfonic acid, which has virtually no antimicrobial activity.

BIOCYN formulation also effectively utilizes an iodophor and magnesium methyl salicylate complex. The iodophor is generated during the catalytic process whereby the iodine molecule is effectively split from the sulfur complex to create two independent antimicrobial agents. The iodophor breaks down the protein structures responsible for the creation of the techoic acid as well as deactivating DNA production. The methyl salicylate acts in a support role by reducing pain and modulating T-cell production. Recently researchers at University of California, San  Diego School of Medicine discovered that T-cells – a type of white blood cell that learns to recognize and attack microbial pathogens – are activated by a pain receptor. The study is the  first to show that these channels are present on T-cells, where they are involved in gating the influx of calcium ions into cells – a process that is required for T-cell activation. "Our study  breaks current dogma in which certain ion channels called CRAC are the only players involved in calcium entry required for T-cell function," said lead author Samuel Bertin, a postdoctoral researcher in the Raz laboratory. "Understanding the physical structures that enable calcium influx is critical to understanding the body's immune  response."

Control and modulation of the pain receptor function effectively controls the production of the T-cells critical for infection fighting. The NMDA receptor “switch” on the neurons is activated by excessive calcium production. In order to modulate T-cell production, the methyl salicylate and magnesium contained in the BIOCYN formulation are used to reduce pain by ionically exchanging calcium Ca2+ receptor ions with magnesium ions. . Magnesium is an essential regulator of calcium flux and the intracellular actions of calcium. Magnesium activates many enzyme systems, including those involved in energy metabolism. It has an essential role in the production of ATP, which is fully functional only when chelated to magnesium and the synthesis of DNA, RNA, and protein. 

The methyl salicylate is transferred into the cellular structure through the trans-dermal absorption of the magnesium ion. When pain is reduced, T-cell production is affected. Unlike salicylic acid which generates a rapid pain reduction spike and then equally as rapid loss of effectiveness, methyl salicylate provides for gradual and sustained pain reduction profile. In doing so, the traumatized area becomes more receptive to the healing process, with less cellular irritation.

BIOCYN® selectively and specifically targets microorganisms. The formulation does not have   the ability to affect healthy mammalian cells. Its formulation is derived in such a manner that it will not oxidize, breakdown or penetrate thick walled animal cells. Because the chemistry is oxygen based, it is not only an effective oxidizer but acts as an efficient antioxidant helping restore healthy cell growth. In its stabilized form it increases the level of oxygen around damaged tissue, thereby stimulating a natural healing process. By comparison, BIOCYN®’s perozone based formulation is as effective as 25% hydrogen peroxide; which while being one of the world’s most effective antimicrobial agents could never be used due its high concentration level.

BIOCYN® has been tested worldwide by some of the most prestigious analysis laboratories. As part of the manufacturing process, each product lot is tested for its’ antimicrobial effectiveness prior to packaging. Its’ ability to clean, sanitize and protect virtually any surface while being non-toxic, non-skin irritating and biologically/environmentally and people safe, makes it the best decision a person can make when looking for a product to address wound  care.